Help
Improve Lives

When people like you participate in clinical trials, we can uncover better ways to treat conditions that may affect you and your loved ones.

Find a Study

COVID-19 Clinical Trials: Meridian is still seeking participants for Phase 2 and 3 COVID-19 vaccine studies in Georgia (Savannah), Louisiana (Baton Rouge), Maryland (Rockville), Nebraska (Grand Island, Norfolk, and Omaha), New York (Binghamton and Endwell), and Sioux City (Iowa). Read more >

Join a study

Clinical trials help scientists develop life-changing medicines, but it starts with you — participation makes it all possible.

Use the Study Finder

Sponsors and CROs

Meridian is a multi-specialty site network for Phase I-IV clinical trials, and will give you access to the right investigators, clinical staff, and patients for your research program.

About Meridian's Network and Capabilities >

Help improve lives.
Enjoy the experience.

Help move science forward

Clinical studies offer a way for almost anyone — regardless of their background — to help improve human health and wellbeing.

Get paid for participating

Most Meridian studies offer payment for time and travel. We'll let you know what to expect during your first phone call with Meridian.

Get early access to new medicines

Clinical studies offer more care options for patients suffering from common, unique, and rare health conditions.

Learn What to Expect When Joining a Study
k
Patients enrolled
k
Studies conducted
Sites across the U.S.

Clients and partners

Meridian provides Phase I-IV research services for Sponsors and CROs developing drugs, medical devices, and diagnostics across numerous therapeutic areas.

Amgen, Abbvie, Abbott, AstraZeneca, Bayer, Bristol-Meyers Squibb, Dermira, Genentech, GlaxcoSmithKline, Johnson and Johnson, Medicago, Merck, Moderna, Novartis, NovoNordisk, Pfizer, Regeneron. Sanofi Pasteur. Seqirus, Takeda
Services and Capabilities

News

Michelle Hurst Joins Meridian Clinical Research as Director of Operational Project Management

January 5, 2021

A Year-End Letter to Meridian Clients and Partners

December 10, 2020

Meridian Clinical Research Opens Dedicated Research Center in Sioux City, IA

November 9, 2020

Meridian Finishes Enrolling Participants for Moderna’s mRNA-1273 Phase 3 COVID-19 Vaccine Clinical Trial

October 22, 2020
Read More Meridian News